The Symrise share $SY1 (+0,2%) is on the road to recovery! 🚀 On Friday, the share price climbed by 1.62% to EUR 98.86, putting it at the top of the DAX. The share price is currently at EUR 97.68 and is thus on its way to breaking away from the recent lows.
One reason for the positive development is the recently announced strategic partnership with the Norwegian company Hofseth BioCare ASA. This collaboration focuses on ingredients from Atlantic salmon that are important for both human health and animal nutrition. Symrise CEO Jean-Yves Parisot emphasizes that this cooperation fits perfectly into the strategy to strengthen the health sector.
Despite the current positive trend, the share is still in the red in 2025. It remains to be seen whether this trend will continue. What do you think about the development of Symrise? Do you think the partnership will take the company forward?